Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca broadens first-line immuno-oncology NSCLC development programme

firstwordpharmaJanuary 18, 2017

Tag: NSCLC , Immuno-Oncology

PharmaSources Customer Service